Search This Blog

Friday, March 8, 2019

Rhythm Pharmaceuticals reports Q4 EPS (74c), consensus (57c)

As of December 31, 2018, cash, cash equivalents and short-term investments were $252.1M, as compared to $148.1M as of December 31, 2017.
https://thefly.com/landingPageNews.php?id=2876501
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)